Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps3-21-06 | Hypothyroidism | ETA2023

Liquid Levothyroxine (L-T4; vs. Tablet L-T4) mantains more stable tsh levels in hypothyroid patients

Fallahi Poupak , Martina Ferrari Silvia , Elia Giusy , Ragusa Francesca , Rosaria Paparo Sabrina , Balestri Eugenia , Botrini Chiara , Patrizio Armando , Mazzi Valeria , Antonelli Alessandro

Hypothyroidism is usually treated with levothyroxine (L-T4), that is present in different formulation. We aim to assess if hypothyroid patients have a better control of thyroid-stimulating hormone (TSH) levels by following a L-T4 therapy in a liquid formulation, with respect to the tablet formulation. We enrolled seven hundred hypothyroid patients treated with liquid L-T4, and three hundred and fifty hypothyroid subjects receiving tablet L-T4 (both groups were matched by age a...

ea0092ps3-21-09 | Hypothyroidism | ETA2023

Efficacy of oral liquid l-thyroxine (L-T4) in controlling hypothyroidism in patients submitted to total thyroidectomy

Ragusa Francesca , Fallahi Poupak , Martina Ferrari Silvia , Elia Giusy , Materazzi Gabriele , Rosaria Paparo Sabrina , Patrizio Armando , Mazzi Valeria , Miccoli Paolo , Antonelli Alessandro

Tablet levothyroxine (L-T4) is the common treatment for hypothyroidism. We aim to investigate the efficacy of L-T4 in liquid formulation in patients recently subjected to total thyroidectomy (without malabsorption or drug interference), with respect to L-T4 tablets. Eighty patients were treated with L-T4 in tablets, whereas one hundred and sixty received liquid L-T4 at the same dosage (1.5 mg/kg/day). All patients started the therapy the day after thyroidectomy, and the drugs ...

ea0092ps3-27-03 | Thyroid Cancer clinical 3 | ETA2023

A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center

Minaldi Elisa , Sabini Elena , Prete Alessandro , Agate Laura , Bottici Valeria , Brogioni Sandra , Torregrossa Liborio , Ugolini Clara , Materazzi Gabriele , Ribechini Alessandro , Bruschini Luca , Molinaro Eleonora , Matrone Antonio , Elisei Rossella

Objectives: Anaplastic thyroid cancer (ATC) is one of the deadliest cancers, with a median overall survival (OS) of 4 months and a disease-specific mortality of ˜100%. Although to date no effective treatment can cure the disease, some anecdotal cases achieved longer survival and very rarely the cure of the disease. Multimodal treatment with surgery, radiotherapy, multikinase inhibitors (MKI) could improve survival in ATC, particularly when surgery is not feasible.<p c...

ea0092ps3-28-04 | Translational 2 | ETA2023

Effect of pazopanib in anaplastic thyroid cancer in primary culture

Martina Ferrari Silvia , Elia Giusy , Ragusa Francesca , Rosaria Paparo Sabrina , Mazzi Valeria , Patrizio Armando , Piaggi Simona , Baldini Enke , Centanni Marco , La Motta Concettina , Antonelli Alessandro , Fallahi Poupak

Anaplastic thyroid cancer (ATC) is usually treated with surgery, external hyperfractionated radiation therapy, and chemotherapy. However, because of the aggressiveness of this type of cancer, these treatments allow about 6-10 months of median survival. Therefore, it is challenging to predict the ATC patient clinical therapy responsiveness. Pazopanib is a multitarget tyrosine kinase inhibitor of VEGF receptors, PDGF, and c-Kit, and its effect in primary human ATC cells (pATC) h...

ea0093oc3 | Oral communication 1: Adrenal Diseases | EYES2023

Preoperative 1 mg dexamethasone suppression test predicts hypothalamus–pituitary–adrenal axis recovery: A one-year retrospective study of adrenal incidentalomas undergoing unilateral adrenalectomy

Bonaventura Ilaria , Tomaselli Alessandra , Angelini Francesco , Ferrari Davide , De Alcubierre Dario , Sada Valentina , Minnetti Marianna , Hasenmajer Valeria , Cozzolino Alessia , Sbardella Emilia , Isidori Andrea , Pofi Riccardo

Background: The evaluation of postoperative adrenal insufficiency (PAI) and hypothalamus–pituitary–adrenal (HPA) axis recovery in patients with adrenal incidentaloma (AI) undergoing unilateral adrenalectomy remains limited.Objectives: We aimed to identify predictive factors for PAI development and evaluate HPA axis recovery in AI patients undergoing unilateral adrenalectomy.Methods: We retrospectively analysed adrenal fun...

ea0065p74 | Adrenal and Cardiovascular | SFEBES2019

Symptomatic hyponatraemia due to valerian extract use

Tzanninis Stamatios

A middle aged woman was admitted to Salisbury District Hospital after she was found to be severely hyponatraemic by her GP. She had been suffering from lightheadedness, headaches and tiredness for a few weeks before her admission but there was no obvious aetiology. Her past medical history included hypertension but she was not on diuretics or any other medication that could affect her sodium levels. Her serum sodium at the GP surgery was 123 and when she was admitted in the Ac...

ea0090ep799 | Pituitary and Neuroendocrinology | ECE2023

Craniopharyngiomas in adult patients: Retrospective, multicentric study in Buenos Aires, Argentina

Mallea-Gil Susana , Glerean Mariela , Rogozinski Amelia , Ballarino Carolina , Battistone Maria Florencia , Danilowicz Karina , Diez Sabrina , Day Patricia Fainstein , Furioso Alejandra , Guitelman Mirtha , Katz Debora , Loto Monica , Martinez Marcela , Miragaya Karina , Sosa Soledad , Slavinsky Patricia , Tkatch Julieta , Vitale Marcelo , Pernas Valeria Gonzalez , Roel Valeria Garcia , Pingel Jesica

Craniopharyngiomas are rare lesions derived from cell remnants of Rathke’s pouch, usually localized in the sellar and suprasellar areas.Objectives: To analyze clinical, endocrine and histological features in a group of patients from Buenos Aires city. To assess efficacy, number of surgeries and complications after surgery or other treatments.Material and methods: Multicentric, retrospective, transversal study. Adult patients w...

ea0081p379 | Endocrine-Related Cancer | ECE2022

First case report of a natural killer T (NK/T) extranodal nasal lymphoma presenting as a diabetes insipidus

Alvarado Rosas Karol Almendra , Sacoto Valeria Gonzalez , Serrano Urzaiz Leticia , Lacarta Benitez Macarena , Contreras Pascual Cristina , Lopez Alaminos Maria Elena , Trincado Pablo , De Diego Garcia Patricia , Acha Perez Javier

A 52-year-old male patient with no past medical history of interest was admitted to our Endocrinology Unit with a clinical course developed in the last month of sudden polyuria, nocturia and polydipsia (8 liters/day) associated with bilateral low back and leg pain, a right-side nasal congestion with eye swelling and paresthesia. Physical examination revealed a doubtful thickening of the nasal mucosa and several two-cm- scattered erythematous disseminated skin lesions. Blood sa...

ea0081p654 | Pituitary and Neuroendocrinology | ECE2022

Pre and post-surgical pituitary dysfunction increase the risk of mortality in patients with non-functioning pituitary tumors: A long-term cohort study

Beyhart Arturo , Mariaca Karla , Salva-Crespi Valeria , Diaz Catalan Daniela , Aldecoa Iban , L Olondo Maria , Sanchez-Dalmau Bernardo , Alobid Isam , Halperin Irene , Mora Mireia , Ensenat Joaquim , Alexandra Hanzu Felicia

Background: Long-term studies evaluating mortality in patients with non-functioning (NF) pituitary tumors (PitNets) are limited, although standardized mortality ratios (SMR) in these patients are reported to be higher than that of general population. There is also no agreement on predictive factors associated to the increased mortality apart from age at diagnosis and glucocorticoid substitution therapy dose.Objective: To assess long-term mortality and as...

ea0081ep740 | Pituitary and Neuroendocrinology | ECE2022

The changing features of a corticotroph PITNET: from silent to Cushing’s disease - case report

Andrei Emilescu Radu , Burcea Iulia Florentina , Dumitriu Roxana Ioana , Nicoleta Năstase Valeria , Ciubotaru Gheorghe Vasile , Gabriela Tătăranu Liga , Poiană Cătalina

Introduction: The spectrum of corticotroph cell pituitary adenomas is very wide, silent corticotroph adenomas (SCAs) being a rare subtype with positive immunohistochemistry for adrenocorticotropic hormone (ACTH), without causing Cushing’s disease. SCAs may exhibit a more aggressive behavior, and the changing of the clinical phenotype towards Cushing’s disease is described. Case report: We present the case of a 74 years old, ex-smoker, hypertens...